Antares Pharma Inc Quick Ratio (ATRS) starting from the first quarter 2022 to first quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Antares Pharma Inc   (NASDAQ: ATRS)

Antares Pharma Inc 's Quick Ratio

ATRS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2022, Quick Ratio deteriorated to 1.21 below Antares Pharma Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 160 other companies have achieved higher Quick Ratio than Antares Pharma Inc in first quarter 2022. While Quick Ratio total ranking in the first quarter 2022 has deteriorated compared to the prior quarter from 2471 to 2508.

Explain Quick Ratio?
How much Cash & cash equivalents ATRS´s has?
What are ATRS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ATRS Quick Ratio (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3		 (Jun 30 2021)
Q2		 (Mar 31 2021)
Q1
Y / Y Current Liabilities Change -25.65 % -10.94 % 1.13 % 87.53 % 104.55 %
Y / Y Cash & cash equivalent Change 11.79 % 26.39 % 9.96 % -12.46 % 10.6 %
Quick Ratio MRQ 1.21 1.25 1.2 0.66 0.8
ATRS's Total Ranking # 2508 # 2471 # 2288 # 2165 # 3004
Seq. Current Liabilities Change -3.74 % 12.1 % -29.96 % -1.63 % 15.3 %
Seq. Cash & cash equivalent Change -7.36 % 17.07 % 27.12 % -18.91 % 4.73 %



Quick Ratio first quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 161
Healthcare Sector # 928
Overall Market # 2508


Quick Ratio Statistics
High Average Low
9.22 2.47 0.66
(Dec 31 2012)   (Jun 30 2021)




Financial Statements
Antares Pharma Inc 's Current Liabilities $ 52 Millions Visit ATRS's Balance sheet
Antares Pharma Inc 's Cash & cash equivalent $ 62 Millions Visit ATRS's Balance sheet
Source of ATRS's Sales Visit ATRS's Sales by Geography


Cumulative Antares Pharma Inc 's Quick Ratio

ATRS's Quick Ratio for the trailling 12 Months

ATRS Quick Ratio

 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months		 (Jun 30 2021)
12 Months		 (Mar 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth 3.75 % 34.47 % 67.08 % 86.76 % 79.03 %
Y / Y Cash & cash equivalent TTM Growth 9.11 % 8.75 % 5.77 % 8.77 % 19.33 %
Quick Ratio TTM 1.05 0.94 0.86 0.84 1
Total Ranking TTM # 5932 # 1597 # 2046 # 5902 # 5886
Seq. Current Liabilities TTM Growth -7.45 % -2.68 % 0.22 % 14.94 % 19.95 %
Seq. Cash & cash equivalent TTM Growth 2.91 % 6.64 % 2.52 % -3.02 % 2.58 %

Quick ratio ranking by company, industry and sector >> Back to ATRS Financial Strength Comparisons >> Go to Compare ATRS Quick Ratio to its Competitors

On the trailing twelve months basis ATRS Cash & cash equivalent increased by 11.79 % in Q1 2022 year on year, while Current Liabilities decreased to $52 millions, this led to increase in in Antares Pharma Inc 's Quick Ratio to 1.05, Quick Ratio remained below ATRS average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 253 other companies have achieved higher Quick Ratio than Antares Pharma Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2021 from 1597 to 5932.

Explain Quick Ratio?
How much Cash & cash equivalents ATRS´s has?
What are ATRS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 254
Healthcare Sector # 1233
Within the Market # 5932


trailing twelve months Quick Ratio Statistics
High Average Low
6.29 1.94 0.8
(Dec 31 2013)   (Jun 30 2021)




Companies with similar Quick Ratio in the quarter ending Mar 31 2022, within Medical Equipment & Supplies Industry Quick RatioMar 31 2022 MRQ Cash & cash equivalentMar 31 2022 MRQ Current Liabilities
Inspira Technologies Oxy B H N Ltd  3.29 $ 6.783  Millions$ 2.064  Millions
Axogen inc   3.23 $ 67.418  Millions$ 20.872  Millions
Mountain Crest Acquisition Corp V  3.22 $ 0.347  Millions$ 0.108  Millions
Sensus Healthcare Inc   3.20 $ 32.830  Millions$ 10.262  Millions
Streamex Corp   3.20 $ 8.665  Millions$ 2.709  Millions
Sanara Medtech Inc   3.20 $ 16.143  Millions$ 5.051  Millions
Silk Road Medical Inc   3.17 $ 93.602  Millions$ 29.499  Millions
Genedx Holdings Corp   3.13 $ 315.002  Millions$ 100.639  Millions
Stereotaxis Inc   3.05 $ 35.095  Millions$ 11.491  Millions
Pear Therapeutics Inc   2.96 $ 137.401  Millions$ 46.379  Millions
Cytosorbents Corporation  2.93 $ 43.023  Millions$ 14.672  Millions
Edap Tms Sa  2.91 $ 70.712  Millions$ 24.313  Millions
Pulse Biosciences Inc   2.88 $ 12.676  Millions$ 4.398  Millions
Solana Company  2.87 $ 6.310  Millions$ 2.199  Millions
Vivos Therapeutics Inc   2.83 $ 17.828  Millions$ 6.292  Millions
Dih Holding Us Inc   2.80 $ 0.594  Millions$ 0.212  Millions
Myomo Inc   2.78 $ 12.943  Millions$ 4.653  Millions
Biolase Inc   2.65 $ 21.809  Millions$ 8.223  Millions
Ss Innovations International Inc  2.60 $ 0.347  Millions$ 0.133  Millions
Sharecare Inc   2.58 $ 253.306  Millions$ 98.167  Millions
Delcath Systems Inc   2.48 $ 20.491  Millions$ 8.258  Millions
Paragon 28 inc   2.44 $ 93.647  Millions$ 38.410  Millions
Intelligent Bio Solutions Inc   2.43 $ 10.756  Millions$ 4.432  Millions
Iridex Corp  2.37 $ 20.621  Millions$ 8.693  Millions
Atricure Inc   2.35 $ 111.397  Millions$ 47.375  Millions
Marizyme Inc   2.30 $ 3.173  Millions$ 1.379  Millions
Achari Ventures Holdings Corp I  2.19 $ 0.615  Millions$ 0.280  Millions
Biotricity Inc   2.17 $ 12.473  Millions$ 5.740  Millions
Inspiremd Inc   2.11 $ 7.798  Millions$ 3.691  Millions
Mimedx Group Inc   2.07 $ 75.676  Millions$ 36.591  Millions

Date modified: 2026-09-08T15:10:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.